ETF · Invesco
XLVP Invesco Health Care S&P US Select Sector UCITS ETF
ISIN IE00B3WMTH43London Stock Exchange: XLVPInvesco Ltd.
- Healthcare
- ETF
- ISA
- SIPP
- Accumulating
Latest close
LSE£708.45
on
- Ongoing charge
- 0.14% a year
- Fund size
- £486m
As of , at least 15 min delayed
At a glance
As of 13/11/2026, XLVP (Invesco Health Care S&P US Select Sector UCITS ETF, ISIN IE00B3WMTH43) closed at £708.45 on the London Stock Exchange. Its ongoing charge is 0.14% a year (about £14 on £10,000). Over the five years to 13/11/2026 its total return was +52.6%, or +19.1% after UK CPIH inflation.
Past returns
- 1 year to 13/11/2026
- +25.9%
- +21.4% after inflation (UK CPIH)
- 3 years to 13/11/2026
- +43.3%
- +29.5% after inflation (UK CPIH)
- 5 years to 13/11/2026
- +52.6%
- +19.1% after inflation (UK CPIH)
£1,000 put in five years ago would have been worth about £1,526 on 13/11/2026 — about £1,191 in today’s spending power, once price rises are taken out. Past performance is not a guide to future returns.
Returns: as reported (delayed data). Inflation: UK CPIH, latest month published.
How we work it out:ReturnsReturns after inflationTotal returnReal returnCPIH
Calendar-year and 12-month returns
Calendar-year returns of Invesco Health Care S&P US Select Sector UCITS ETF in pounds (price, with income reinvested in the fund): 2022 +9.0%, 2023 −3.9%, 2024 +5.6%, 2025 +4.3%; 2026 to 13/11/2026 +25.2%. Returns of Invesco Health Care S&P US Select Sector UCITS ETF in pounds (price, with income reinvested in the fund) over the 12 months to 30/09/2026: +20.9%; to 30/09/2025: −5.1%; to 30/09/2024: +9.8%; to 30/09/2023: −2.9%; to 30/09/2022: +20.3%.
| Year | Return | After inflation | Return shown as a bar |
|---|---|---|---|
| to | +25.2% | +21.2% | |
| to | +4.3% | +0.7% | |
| to | +5.6% | +2.0% | |
| −3.9% | −7.7% | ||
| +9.0% | −0.2% |
| 12 months to | Return | After inflation |
|---|---|---|
| from | +20.9% | +16.6% |
| from | −5.1% | −8.8% |
| from | +9.8% | +7.0% |
| from | −2.9% | −8.8% |
| from | +20.3% | +10.6% |
As of , inflation: UK CPIH
How we work it out:Calendar-year returnsWhat a calendar-year return isAccumulating and distributing
Risk: volatility and largest fall
Volatility (annualised)
14.2%over 5 years
| 1 year | 17.0% |
|---|---|
| 3 years | 14.6% |
| 5 years | 14.2% |
Annualised from weekly returns. Higher means bumpier.
- Largest fall since November 2021
- −19.0%
- From to
- Lowest 12-month return
- −16.8%
- 12 months to
- Highest 12-month return
- +30.0%
- 12 months to
- Below its highest weekly close since November 2021
- 0.0%
- High of , latest
In words: Volatility of Invesco Health Care S&P US Select Sector UCITS ETF in pounds, annualised from weekly returns to 13/11/2026: 17.0% over 1 year, 14.6% over 3 years, 14.2% over 5 years. Largest fall in the price of Invesco Health Care S&P US Select Sector UCITS ETF since November 2021, in pounds: −19.0% from 31/01/2025 to 23/05/2025. The lowest 12-month return of Invesco Health Care S&P US Select Sector UCITS ETF in pounds (price, with income reinvested in the fund) since January 2021 was −16.8% (12 months to 08/08/2025); the highest was +30.0% (12 months to 08/04/2022). On 13/11/2026 the price of Invesco Health Care S&P US Select Sector UCITS ETF was at its highest weekly close since November 2021, in pounds.
As of , price, with income reinvested in the fund
How we work it out:Risk figuresFallsVolatilityLargest fall
Charges compared with similar funds
- Ongoing charge
- 0.14%
- a year
- On £10,000
- £14
- a year, roughly
- Over five years
- £70
- of £10,000, before growth
- 1 charge less
- 0 the same
- 27 charge more
Ongoing charge of Invesco Health Care S&P US Select Sector UCITS ETF 0.14% a year. Compared on 14/11/2026, 27 of the 28 other healthcare funds charge more, 0 the same and 1 less (share classes counted once).
As of
A lower charge is not a promise of a higher return: what the fund holds matters more.
As of
Read more:Ongoing charge (OCF)OCF and TERFee dragHow charges add up
In plain English
Invesco Health Care S&P US Select Sector UCITS ETF is an exchange-traded fund (ETF) from Invesco, launched in 2009.
It tracks the S&P Select Sector Capped 20% Health Care Index.
You buy and sell it through a share-dealing account or platform during stock-market hours, like a share.
Its ongoing charge is 0.14% a year — about £14 a year on every £10,000 invested, taken from the fund's value rather than billed to you.
Income from its investments is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you.
Healthcare: Pharmaceutical, biotech and medical-equipment companies.
Terms:ETFIndex fundUCITSAccumulating or incomeShare classISIN
Key facts
- Ticker
- XLVP
- ISIN
- IE00B3WMTH43
- Also listed as
- XLVS (London Stock Exchange, US dollars)
- Provider
- Invesco
- Tracks
- S&P Select Sector Capped 20% Health Care Index
- Structure
- ETF
- An exchange-traded fund: bought and sold on the stock exchange through the day, like a share.
- Income
- Accumulating
- Income is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you.
- Ongoing charge
- 0.14% a year · about £14 on £10,000
- Fund size
- £486m
- Launched
- Domicile
- Ireland
- UK reporting fund status
- Yes — on HMRC’s list of reporting funds (list of )
- Reporting fund since . What reporting fund status means
- Can usually be held in
- ISA and SIPP
- Check with your platform: each decides which funds it offers.
- Currency hedged
- No
- Price currency
- Pounds (GBP)
- Category
- Healthcare
Price chart
Over the last year, the closing price went from £568.20 on 14/11/2025 to £708.45 on 13/11/2026 (+24.7%). The lowest close shown was £521.10 on 08/05/2026 and the highest £708.45 on 13/11/2026.
One close a week. Before 31/07/2026 the closes are from the weekly price history for this listing; from then on, the closing prices we have recorded.
As of , at least 15 min delayed
Five years of prices, and after inflation
262 weekly closes, from 12/11/2021 to 13/11/2026. The same history in November 2026 pounds, adjusted with CPIH inflation.
Create a free account to see the 5-year price chart and the after-inflation chart
Sign-up takes an email address. There is no card to enter and nothing to pay.
How we work it out:Prices and returnsNAV and price
What it holds
- Holdings
- 60
- on record
- Ten largest
- 60.9%
- of the whole fund
- Effective number of holdings
- 18
- As concentrated as this many equal-sized holdings (how it is worked out)
- Largest holding
- 15.2%
- Eli Lilly
Top 10 holdings
| Rank# | Holding | Weight as a percentage of the fund |
|---|---|---|
| 1 | Eli LillyLLY | 15.20% |
| 2 | Johnson & JohnsonJNJ | 10.50% |
| 3 | AbbVieABBV | 7.60% |
| 4 | MerckMRK | 5.90% |
| 5 | UnitedHealth GroupUNH | 5.40% |
| 6 | Thermo Fisher ScientificTMO | 4.10% |
| 7 | AmgenAMGN | 3.70% |
| 8 | Gilead SciencesGILD | 3.00% |
| 9 | Abbott LaboratoriesABT | 2.80% |
| 10 | PfizerPFE | 2.70% |
As of , holdings as published
Where it invests
The portfolio by sector, country and type of asset, as a share of the whole fund. Bonds, cash and positions without a classification are shown as they come, not guessed.
By country
- United States97.8%
- Ireland2.1%
See the full portfolio
Every holding with search and filters, the whole breakdown by sector, country and type of asset, a map of the 60 largest and what changed since .
All holdings
The fund publishes 60 holdings; the ten largest make up 60.9% of it.
Create a free account to see the full holdings list
Sign-up takes an email address. There is no card to enter and nothing to pay.
Sector split
As a share of the whole fund. 99.9% of it is classified by sector; bonds, cash and positions that cannot be matched are left out rather than guessed.
- Health Technology82.3%
- Health Services11.5%
- Distribution Services3.4%
- Retail Trade1.8%
- Technology Services0.7%
- Commercial Services0.2%
Holdings:Compare what it holds with another fundHoldings overlapHow overlap is measured
Risk and return in depth
Sharpe, Sortino and Calmar ratios
Sharpe, Sortino and Calmar ratios over 1, 3 and 5 years, from weekly returns in pounds.
With a free accountRolling returns
The full range of 254 rolling 12-month returns since January 2021, and of 150 rolling three-year returns, in pounds, with how often they were above zero.
With a free accountLargest falls and recoveries
The 3 largest falls since November 2021, in pounds, with how many weeks each took to reach its low and to recover.
With a free account
Create a free account to see the risk ratios, every rolling return and each large fall and its recovery
Sign-up takes an email address. There is no card to enter and nothing to pay.
Moves compared with a similar fund
Correlation and beta of weekly returns in pounds against iShares Core S&P 500 UCITS ETF, over the three years to 13/11/2026 (154 weeks).
Pro
Pro — currently by invitation
Pro includes moves against a comparable fund
Pro is open by invitation while it is being built. There is nothing to buy. To ask about access, email [email protected].
Questions people ask
What is the ongoing charge of XLVP?
The ongoing charge of XLVP is 0.14% a year — about £14 a year on every £10,000 invested, taken from the fund’s value rather than billed to you. Platform and dealing fees are charged separately. Ongoing charge of Invesco Health Care S&P US Select Sector UCITS ETF 0.14% a year. Compared on 14/11/2026, 27 of the 28 other healthcare funds charge more, 0 the same and 1 less (share classes counted once).
What does XLVP track?
XLVP tracks the S&P Select Sector Capped 20% Health Care Index.
Is XLVP accumulating or distributing?
XLVP is accumulating: income is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you.
What is the ISIN of XLVP?
The ISIN of XLVP is IE00B3WMTH43. An ISIN identifies one exact share class of a fund; XLVP is its ticker on the London Stock Exchange. The same share class is also listed as XLVS (London Stock Exchange, US dollars).
What does XLVP hold?
As of 30/09/2026, XLVP holds 60 positions, according to its published holdings. The largest is Eli Lilly at 15.20% of the fund; the ten largest make up 60.9%. Its ten largest holdings are Eli Lilly (15.20%), Johnson & Johnson (10.50%), AbbVie (7.60%), Merck (5.90%), UnitedHealth Group (5.40%), Thermo Fisher Scientific (4.10%), Amgen (3.70%), Gilead Sciences (3.00%), Abbott Laboratories (2.80%) and Pfizer (2.70%).
What were XLVP’s returns in each of the last five years?
Calendar-year returns of XLVP in pounds (price, with income reinvested in the fund): 2022 +9.0%, 2023 −3.9%, 2024 +5.6%, 2025 +4.3%; 2026 to 13/11/2026 +25.2%. Past performance is not a guide to future returns.
How has XLVP done after inflation?
Over the five years to 13/11/2026 XLVP’s total return was +52.6%, or +19.1% after UK CPIH inflation. Past performance is not a guide to future returns.
Similar funds
- XWHSXtrackers MSCI World Health Care UCITS ETF0.25% a year · £3.4bn
- IHCUiShares S&P 500 Health Care Sector UCITS ETF0.15% a year · £2.7bn
- DRDRiShares Healthcare Innovation UCITS ETF0.40% a year · £1.3bn
- XSHCXtrackers MSCI USA Health Care UCITS ETF0.12% a year · £1.2bn
- BTEKiShares NASDAQ US Biotechnology UCITS ETF0.35% a year · £1.0bn
- CH5Amundi STOXX Europe 600 Healthcare UCITS ETF -Acc- Capitalisation0.30% a year · £833m
- ESIHiShares MSCIEurope Health Care Sector UCITS ETF AccumEUR0.18% a year · £798m
- 0DW6Amundi MSCI World Health Care UCITS ETF EUR ACC0.30% a year · £792m
Fund documents and methods
Methodology:ReturnsCategoriesAll methods
A machine-readable copy of this page: Markdown.